Avanos Medical (NYSE:AVNS – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Wednesday, October 30th. Analysts expect Avanos Medical to post earnings of $0.36 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS and its FY 2024 guidance at 1.300-1.450 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Avanos Medical (NYSE:AVNS – Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. During the same period last year, the firm earned $0.24 EPS. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Avanos Medical Trading Up 0.5 %
Shares of AVNS opened at $22.34 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The firm has a 50 day simple moving average of $23.44 and a 200-day simple moving average of $21.47. Avanos Medical has a 1-year low of $17.24 and a 1-year high of $25.36. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 131.41 and a beta of 0.91.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on AVNS
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
- Five stocks we like better than Avanos Medical
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Top Stocks It’s Not Too Late to Buy Today
- How to Invest in Blue Chip Stocks
- ASML Stock Slides – A Buying Opportunity in Semiconductors?
- 3 Stocks to Consider Buying in October
- 3 Stocks to Score from 40% YoY Data Center Capex Spending in 2025
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.